Status:
COMPLETED
Neurodevelopment of Hypoglycemic Neonates
Lead Sponsor:
Montefiore Medical Center
Conditions:
Neonatal Hypoglycemia
Neurodevelopmental Disorders
Eligibility:
All Genders
18-24 years
Brief Summary
The investigators propose to prospectively conduct a neurodevelopmental evaluation of SGA and late preterm neonates who underwent risk-based screening for hypoglycemia at newborn nursery during the fi...
Detailed Description
Neonatal hypoglycemia is the most common metabolic problem in neonates and a preventable cause of brain injury in infancy. Key risk factors for neonatal hypoglycemia include being born preterm, small ...
Eligibility Criteria
Inclusion
- Born at 35 weeks or more of gestation
- Birth weight of 2000 g or more
- Indication for routine screening for hypoglycemia: late preterm infants (gestational age from 35 weeks 0 days to 36 weeks 6 days) and newborns who were SGA (birth weight below the 10th percentile on the 2013 Fenton curve).
Exclusion
- Neonates with indication for hypoglycemia screening - screening not properly done or missing
- Unable to reach the subject for neurodevelopmental assessment
- Non-English speaking subjects
Key Trial Info
Start Date :
July 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 19 2024
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT04875624
Start Date
July 14 2021
End Date
July 19 2024
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center, Weiler Hospital
The Bronx, New York, United States, 10461